financetom
Business
financetom
/
Business
/
Eli Lilly Ties Up With Ro to Improve Availability of Weight-Loss Drug Zepbound in Vials
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Eli Lilly Ties Up With Ro to Improve Availability of Weight-Loss Drug Zepbound in Vials
Dec 11, 2024 8:45 AM

11:10 AM EST, 12/11/2024 (MT Newswires) -- Eli Lilly ( LLY ) is enhancing accessibility to single-dose vials of Zepbound via a collaboration with telehealth service provider Ro, which announced the offering of the weight-loss drug on its platform on Wednesday.

Ro said the vials will be delivered directly to clinically eligible patients.

An Eli Lilly ( LLY ) representative and Ro did not immediately reply to MT Newswires' requests for information on the terms of the partnership.

Ro Chief Executive Zach Reitano was quoted in a Bloomberg report as saying that the company has "no financial arrangement" with Eli Lilly ( LLY ) regarding the Zepbound offering on its site.

Price: 790.63, Change: -8.96, Percent Change: -1.12

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved